The Office of the Chief Scientist provides strategic leadership, coordination, and expertise, supporting scientific excellence, innovation and capacity to achieve FDA's public health mission.
The Office comprises the Office of Counterterrorism and Emerging Threats (OCET), the Office of Health Informatics (OHI), Office of Regulatory Science and Innovation (ORSI), the Office of Scientific Integrity (OSI), the Office of Scientific Professional Development (OSPD), the Office of Minority Health (OMH), and FDA's National Center for Toxicological Research (NCTR).
- Fosters development and use of innovative technologies to meet public health needs
- Supports scientific excellence and the professional development of FDA scientists in all areas (e.g., population/statistical, review, laboratory and manufacturing sciences), including through the Commissioner's Fellowship Program, continuing education, and scientific interactions with universities and others
- Provides strategic leadership and support for high quality, collaborative, scientific activities that advance regulatory science and address important public health issues concerning FDA regulated products, including their evaluation, quality, safety and effectiveness
- Provides support and guidance for the NCTR to serve as a national FDA resource for mission driven regulatory science
- Provides cross-agency scientific coordination (e.g., for emerging technologies, scientific issues involving multiple agency components, standards coordination, the FDA Science Board, and science communication)
- Supports scientific outreach, training, and collaboration, including research and development that engage other agencies, global regulatory partners, academia, innovators, and consumers
- Supports science and public health activities to effectively anticipate and respond to counterterrorism and emerging deliberate and natural threats (e.g., chemical, biological, radiological, and nuclear) to US and global health and security including through the Office of Counterterrorism and Emerging Threats
- Provides core scientific leadership and technical expertise, and ensuring agency capacity, for advanced bioinformatics activities needed to support FDA programs. Serve as an agency and government resource for excellence, methods development, outreach and partnerships in advanced bioinformatics science
- Leads agency efforts to protect and enhance scientific integrity, and, where substantive scientific differences of opinion arise and require review at the FDA level, addresses them through appropriate processes intended to protect both FDA’s mission and the integrity of its science.
- Centers of Excellence in Regulatory Science and Innovation (CERSI)
- Regulatory Science Extramural Research and Development Projects
- Don't Miss the Monthly FDA Grand Rounds. Register for CE Credit
- Watch the Complete Webcast of the 2017 FDA Science Forum
- Office of the Chief Scientist
- Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO1
Silver Spring, MD 20993
- (301) 796-4880